Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Liver Transpl. 2014 Oct 24;20(11):1306–1316. doi: 10.1002/lt.23950

Table 1.

Clinical characteristics of first orthotopic liver transplant recipients in the Organ Procurement and Transplantation Network Database (OPTN) 2002–2012

Characteristic N = 54,697
Age, mean ± SD, years 54.0 ± 9.5
Sex (women), No (%) 17,198 (31.4)
Race & ethnicity, No (%)
 Non-Hispanic White 39,747 (72.7)
 Black 4820 (8.8)
 Hispanic 7165 (13.1)
 Asian 2435 (4.5)
 Other 530 (0.97)
Socioeconomic Status, No (%)
 Less than high school education 2405 (4.4)
 Working for income at time of transplant 11,463 (21.0)
Etiology of Liver Disease, No (%)
 Hepatitis C 15,529 (33.5)
 Alcohol 11,220 (24.2)
 NASH 3085 (6.7)
 Other 16,545 (30.2)
Calculated MELD score at transplant, mean ± SD 19.0 ± 10.4
Waitlist time, mean ± SD, days 273.6 ± 493.5
Hepatocellular Carcinoma, No (%) 12,694 (23.2)
Simultaneous liver-kidney transplant, No (%) 3206 (5.9)
BMI (kg/m2) at transplant, mean ± SD 28.2 ± 5.6
Pretransplant Comorbid CVD Conditions, No (%)
 Angina 790 (3.4)
 Cerebrovascular Disease 137 (0.6)
 Diabetes 13902 (25.4)
 Hypertension 4399 (19.6)
Functional status at transplant, No (%)
 Independent 24411 (49.7)
 Partially dependent 12229 (24.9)
Totally dependent 12528 (25.5)
Hospitalization status at transplant, No (%)
 Not hospitalized 41090 (75.2)
 Hospitalized not in ICU 9032 (16.5)
In ICU 4489 (8.2)
Revised Cardiac Risk Index (RCRI), mean 1.79 ± 1.21

Abbreviations: SD, standard deviation; NASH, nonalcoholic steatohepatitis; MELD, model for end-stage liver disease; BMI, body mass index; ESLD, end-stage liver disease; CVD, cardiovascular disease; RRT, renal replacement therapy; ICU, intensive care unit; TIPS, transjugular intrahepatic portosystemic shunt